GlassScriptPhysician profile
Adam L Esham
NPI 1801090469
$700.64
in general payments reported to CMS, 2019-2025
10 companies · $68.62 in 2025
The $68.62 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.07 · 2020: $94.02 · 2021: $72.30 · 2022: $192 · 2023: $140 · 2024: $104 · 2025: $68.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $254.99 | 2020-2022 | |
| Boston Scientific Corporation | $165.64 | 2019-2025 | Lumenis Pulse 120h, Lithovue, Moses 550 Dfl |
| Ethicon US, LLC | $77.96 | 2020-2024 | Echelon; Endopath, Harmonic |
| C. R. Bard, INC. & Subsidiaries | $71.19 | 2023 | Bard Urinary Drainage Bag |
| Karl Storz Endoscopy-America | $40.14 | 2021 | |
| Ambu INC. | $24.59 | 2024 | |
| Laborie Medical Technologies Corp. | $23.82 | 2025 | |
| Tolmar, INC. | $15.35 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $13.89 | 2019 | |
| Teleflex LLC | $13.07 | 2023 | Urolift |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Esham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.